Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with <i>Pseudomonas</i> Airway Infection

Abstract

FTI maintained the substantial improvements in FEV(1) % predicted achieved during the AZLI run-in and was well tolerated. FTI is a promising antipseudomonal therapy for patients with CF.